Remarkable Response to Olaparib in a Patient with Combined Hepatocellular-Cholangiocarcinoma Harboring a Biallelic BRCA2 Mutation

Combined hepatocellular cholangiocarcinoma (cHCC-CC) is a rare subtype of primary liver malignancy characterized by aggressive behavior and poor prognosis. Radial surgical resection is the standard curative treatment. However, effective therapeutic options for recurrent or metastatic cHCC-CC are sti...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Yu-Li, Ng, Ca Tung, Jan, Yi-Hua, Hsieh, Yi-Lin, Wu, Chia-Ling, Tan, Kien Thiam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254587/
https://www.ncbi.nlm.nih.gov/pubmed/34234458
http://dx.doi.org/10.2147/OTT.S317514

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254587/
https://www.ncbi.nlm.nih.gov/pubmed/34234458
http://dx.doi.org/10.2147/OTT.S317514

Ejemplares similares